Related Experiment Video
Updated: Jun 24, 2026

Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
Published on: August 26, 2009
Nongenetic engineering nanozyme proximity labeling reveals subcellular in situ interactomes and trafficking pathways
Chao Jiang1,2, Yiyang Fu1, Baichuan Jin1
1Zhejiang Cancer Hospital, Zhejiang Provincial Key Laboratory of Protein Detection Technology and Diagnostic Equipment, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, People's Republic of China.
Abstract:
Elucidating the dynamic interactions between nanocarriers and cellular machinery is critical for advancing targeted nanomedicine. However, the optical microscopy imaging techniques can only provide a generalized view of nanomedicine localization. Proteomics approaches require cell lysis which disrupt native protein coronas during isolation, obscuring real-time intracellular trafficking mechanisms. Although proximity labeling enables in situ investigation of intracellular protein-protein interactions, it relies on genetically engineered enzyme fusion, thus limiting applicability across diverse systems. In this study, we report nanozyme proximity labeling (NPL), a genetic engineering-free strategy that harnesses the intrinsic peroxidase activity of Fe3O4 nanoparticles (NPs) to biotinylate proximal proteins within live cells. NPL achieves rapid biotinylation of NP-interacting proteins during intracellular transit. Using streptavidin pulldown and LC-MS/MS, we mapped high-fidelity in situ interactomes and suggested distinct trafficking pathways for mitochondrial-targeted Fe3O4@TPP NPs and nontargeted Fe3O4 NPs. Our NPL interrogates the native NP-protein corona-organelle interfaces, offering a generalizable platform to decipher subcellular targeting mechanisms and accelerate nanomedicine optimization.

